Search results
Rising cases of Breast cancer: Everything you need to know so far
Business Standard India· 16 hours agoBreast cancer is a rising health concern for women in both ruraland urban areas of India. This type...
Boehringer Ingelheim and Gubra begin Phase I trial of drug candidate for obesity
Clinical Trials Arena· 4 days agoAll treatment doses will be administered via subcutaneous injection. The trial will have an...
Want to quit smoking? WHO releases first-ever treatment guidelines for tobacco cessation
Financial Express· 3 days agoIn a first, the World Health Organization (WHO) on Tuesday recommended a comprehensive set of...
Cardiological Society of India launches first-ever guidelines for dyslipidemia management - ET...
The Economic Times· 2 days agoGuidelines For Dyslipidemia Management: Dyslipidemia, characterized by high total cholesterol,...
As monsoon advances, central Travancore in the grip of fever
The Hindu· 2 days agoWith monsoon gathering momentum in the State, the central Travancore districts of Kottayam and...
US FDA clears Alzheimer’s drug for early stage treatment: Is this a breakthrough therapy?
Indian Express· 3 days agoThis clearance is significant because Donanemab is the only drug that has been able to demonstrate...
Rob Thomas' Sweet Birthday Wish for His Senior Dog Brings All the Feels
Parade· 12 hours agoIn 2020. Thomas spoke to People magazine about his own rescue pups and The Sidewalk Angels, "But...
Hina Khan Chops Off Her Hair Post Breast Cancer Diagnosis, Her Mom Wails In Corner - Watch
Times Now· 2 days agoOn June 28, Hina Khan informed her fans and followers that she has been diagnosed with stage 3 breast cancer. The actress penned a note in which she revealed that her < ...
USFDA approves second Alzheimer's drug that can modestly slow disease
Business Standard India· 3 days agoUS officials have approved another Alzheimer's drug that can modestly slow the disease, providing a...
Boehringer and OSE to advance cancer immunotherapy to clinics
Pharmaceutical Technology· 2 days agoOSE Immunotherapeutics CEO Nicolas Poirier said: “We are thrilled to see the SIRPα project moving...